__timestamp | Ascendis Pharma A/S | Rhythm Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 19698000 | 5280000 |
Thursday, January 1, 2015 | 40528000 | 7148000 |
Friday, January 1, 2016 | 66022000 | 19594000 |
Sunday, January 1, 2017 | 99589000 | 22894000 |
Monday, January 1, 2018 | 140281000 | 50337000 |
Tuesday, January 1, 2019 | 191621000 | 109450000 |
Wednesday, January 1, 2020 | 260904000 | 90450000 |
Friday, January 1, 2021 | 295867000 | 104128000 |
Saturday, January 1, 2022 | 379624000 | 108630000 |
Sunday, January 1, 2023 | 413454000 | 134951000 |
Monday, January 1, 2024 | 307004000 |
Unleashing insights
In the competitive world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Ascendis Pharma A/S and Rhythm Pharmaceuticals, Inc. have demonstrated significant commitment to R&D, with Ascendis Pharma A/S increasing its R&D expenses by over 2,000% from 2014 to 2023. This Danish company has consistently outpaced its American counterpart, Rhythm Pharmaceuticals, Inc., whose R&D spending grew by approximately 2,500% during the same period.
Ascendis Pharma A/S's R&D investment peaked in 2023, reaching nearly 4.1 times its 2014 expenditure. Meanwhile, Rhythm Pharmaceuticals, Inc. saw its highest R&D spending in 2023, marking a 25% increase from the previous year. These trends underscore the relentless pursuit of innovation in the biopharma sector, as both companies strive to bring groundbreaking therapies to market.
Novo Nordisk A/S vs Ascendis Pharma A/S: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
R&D Insights: How GSK plc and Ascendis Pharma A/S Allocate Funds
argenx SE or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development Investment: Genmab A/S vs Ascendis Pharma A/S
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
R&D Insights: How Ascendis Pharma A/S and Xenon Pharmaceuticals Inc. Allocate Funds
Ascendis Pharma A/S vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds